This is a common type of skin cancer, often found on the face, ears, lips, or neck. It can also occur in other parts of the body, like the lungs, esophagus, or genitals. It develops from the squamous cells, which are flat cells that make up the outer layer of the skin.
Every report comes from a Lived member, sent anonymously.
Have you had Mohs Surgery for Squamous Cell Carcinoma?
Squamous cell carcinoma (SCC) is a cancer that starts in squamous cells, the thin, flat cells that form the outer layer of the skin and line moist surfaces inside the body, such as the mouth, throat, airways, esophagus, cervix and anus. The name describes the kind of cell the cancer grows from rather than one location. SCC of the skin and SCC of the lung look alike under a microscope, but they have different causes and are treated and followed quite differently. The skin is the most common site. About 2 in 10 skin cancers are squamous cell carcinomas, making SCC the second most common skin cancer after basal cell carcinoma. It usually appears on sun-exposed skin such as the face, ears, lower lip, neck, arms and backs of the hands, often as a rough, scaly or crusted patch, a firm raised red bump, or a sore that does not heal and may bleed. Most skin cases are found early and removed completely. A smaller number grow deeper or spread, which is why a changing spot deserves a clinician's look rather than waiting. Inside the body, SCC accounts for most cancers of the mouth, throat and voice box, anus, cervix and vagina, and is one of the main types of lung cancer. In those places the symptoms come from the organ involved, such as hoarseness, a sore in the mouth or a cough that will not go away.
SCC develops when damage to the genetic material of squamous cells builds up until the cells grow out of control. What causes that damage depends largely on where the cancer starts. For skin SCC, long-term ultraviolet (UV) light from the sun or tanning beds is the main cause, which is why the cancers cluster on the face, ears, lips and hands. Risk is higher with fair skin that burns easily, a history of sunburns, older age and a previous skin cancer. Actinic keratoses, rough scaly patches caused by sun damage, are not cancer but sometimes turn into SCC. A weakened immune system raises risk considerably, especially in people taking anti-rejection medicines after an organ transplant. Long-lasting skin inflammation, old scars or chronic wounds, past radiation treatment and arsenic exposure also contribute. People of all skin colors can develop skin SCC. Inside the body, the main causes are different. Tobacco and alcohol cause most squamous cell cancers of the mouth and voice box, and using both raises risk more than either alone. Long-lasting infection with a high-risk type of human papillomavirus (HPV), a very common sexually transmitted virus, causes nearly all cervical cancer, most anal cancer and a growing share of throat cancers involving the tonsils and base of the tongue. Smoking is the major risk factor for lung cancer, including the squamous type. Having a risk factor does not mean someone will develop cancer, and SCC also occurs in people with none of them.
A biopsy is the only way to confirm squamous cell carcinoma. A clinician removes all or part of the abnormal area, and a pathologist examines it under a microscope. For a skin spot this is usually a short office procedure with local numbing: the growth may be shaved off, a small circle of skin may be removed with a punch tool, or the whole growth may be cut out. When SCC is suspected inside the body, the sample is usually taken during an exam with a scope or a closer look at the area involved, such as the throat or cervix. For skin SCC, the size of the tumor, how deeply it has grown and where it sits on the body help decide whether further tests are needed. Most small skin cancers of this type need none. When a skin SCC is large or deep, or when the cancer started inside the body, staging tests check whether it has spread. These can include an examination or ultrasound of nearby lymph nodes, a lymph node biopsy, and imaging such as CT (computed tomography) or PET (positron emission tomography) scans. The result is a stage from 0 to IV. Stage 0, also called carcinoma in situ, means the cancer is confined to the top layer of tissue; higher stages mean it has grown larger or spread.
Treatment depends on where the cancer started, its size and stage, and the person's overall health. For most skin SCC, the goal is to remove the cancer completely while sparing healthy skin, and this is usually successful. Surgery is the main option for skin SCC. A simple excision cuts out the tumor along with a margin of normal skin. Mohs surgery removes the cancer in thin layers, checking each one under a microscope during the same visit until no cancer remains. It spares as much healthy tissue as possible and is often used on the face, fingers or genitals, or for tumors without a clear border. Small, shallow cancers may instead be scraped away and the base treated with an electric needle (curettage and electrodesiccation), or frozen with liquid nitrogen (cryosurgery). SCC confined to the top layer of skin can sometimes be treated with prescription creams such as imiquimod or fluorouracil, or with photodynamic therapy, in which a light-activated medicine is applied to the skin and then exposed to a special light. Radiation therapy is an alternative for people who cannot have surgery and may be added after surgery when the risk of the cancer returning is higher. When skin SCC has spread or cannot be cured with surgery or radiation, immunotherapy is the main treatment. Cemiplimab (Libtayo) and pembrolizumab (Keytruda) are immune checkpoint inhibitors, medicines given by infusion that release a brake on the immune system so it can attack the cancer. The trade-off is that the immune system can also attack healthy organs, causing inflammation of the lungs, bowel, liver, hormone glands, kidneys or skin, and these medicines can trigger rejection of a transplanted organ, which matters greatly for transplant recipients. Cemiplimab is also approved after surgery and radiation for people whose skin SCC has a high risk of coming back. SCC of the mouth, throat, lung, cervix, anus and other organs is treated by cancer teams that specialize in that site, using combinations of surgery, radiation, chemotherapy and immunotherapy that differ from skin cancer care.
Most people with skin SCC have a small cancer removed in a single procedure, and a scar is the main lasting effect. Outlook is generally excellent when skin SCC is found and treated early. It depends mostly on the stage, whether the immune system is weakened, tobacco use and overall health. The longer-term issue is that one skin cancer usually reflects years of sun damage. A treated SCC can come back in the same place, and having had one raises the chance of new skin cancers elsewhere. Follow-up therefore means regular full skin checks with a clinician, often a dermatologist, along with checking your own skin between visits, including the treated area and places that are hard to see. Daily sun protection, such as shade, protective clothing, hats and sunscreen, and avoiding tanning beds help lower the chance of new cancers. People who take anti-rejection medicines or otherwise have weakened immunity tend to develop more skin cancers and usually need closer surveillance. For SCC that started inside the body or has spread, the outlook, the effects of treatment on eating, speaking or breathing, and the follow-up schedule depend heavily on the organ involved and the stage. The treating cancer team plans that follow-up.
Arrange a visit for any skin spot that is new, growing, scaly, crusted or bleeding, or a sore that does not heal. Do the same for a mouth sore or white or red patch that persists, a lump in the neck, hoarseness or a sore throat that does not go away, difficulty swallowing, or a cough that keeps getting worse. These symptoms often have less serious causes, but they are worth checking. After treatment, contact your care team promptly about a lump, sore or change at the treated site or a new lump nearby. If you are receiving immunotherapy, call your care team right away about new diarrhea, cough or shortness of breath, yellowing of the skin or eyes, or a severe rash, because immune side effects are easier to manage when caught early.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Squamous Cell Carcinoma is like, what's helped you, or ask the community a question.